Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Beluga NV | BELU | Mar 27, 2024 | 2.00 | 0.00 |
Belysse Group N.V. | BELYS | Mar 27, 2024 | 0.79 | +4.52 |
Biocartis Group NV | BCART | Mar 27, 2024 | 0.29 | 0.00 |
Biosenic | BIOS | Mar 27, 2024 | 0.02 | 0.00 |
Biotalys | BTLS | Mar 27, 2024 | 3.04 | -1.30 |
Boeing | BOEI | Mar 27, 2024 | 224.00 | 0.00 |
Bone Therapeutics S.A. | BOTHE | Mar 27, 2024 | 0.29 | 0.00 |
Bpost S.A. / N.V | BPOST | Mar 27, 2024 | 3.46 | +1.83 |
Brederode S.A. | BREB | Mar 27, 2024 | 103.00 | -1.53 |
Campine nv | CAMB | Mar 27, 2024 | 67.50 | 0.00 |
Candela Invest | CAND | Mar 27, 2024 | 2.90 | 0.00 |
Care Property Invest NV/SA | CPINV | Mar 27, 2024 | 12.76 | -1.24 |
Celyad Oncology SA | CYAD | Mar 27, 2024 | 0.35 | 0.00 |
Cenergy Holdings | CENER | Mar 27, 2024 | 7.14 | +0.42 |
Chevron | CHTEX | Mar 27, 2024 | 170.32 | 0.00 |
Choice NV | MLTV | Mar 27, 2024 | 1.49 | 0.00 |
Cisco Systems | CIS | Mar 27, 2024 | 53.06 | 0.00 |
Cofinimmo | COFB | Mar 27, 2024 | 59.10 | +1.90 |
Cofinimmo PRF PERPETUAL EUR | COFP1 | Mar 27, 2024 | 127.00 | 0.00 |
Cofinimmo PRF PERPETUAL EUR - Registered 0% | COFP2 | Mar 27, 2024 | 95.00 | 0.00 |
Colruyt Group N.V. | COLR | Mar 27, 2024 | 43.34 | +0.44 |
Compagnie du Bois Sauvage S.A. | COMB | Mar 27, 2024 | 244.00 | +0.83 |
Compagnie d`Entreprises CFE SA | CFEB | Mar 27, 2024 | 7.23 | +1.26 |
Connect Group | CONN | Mar 27, 2024 | 1.53 | 0.00 |
Crescent NV | OPTI | Mar 27, 2024 | 0.01 | +4.88 |
Cumulex NV | CLEX | Mar 27, 2024 | 1.01 | -3.81 |
CURETIS | CURE | Mar 27, 2024 | 0.29 | 0.00 |
Deceuninck NV. | DECB | Mar 27, 2024 | 2.24 | 0.00 |
Deme Group N.V. | DEME | Mar 27, 2024 | 140.60 | -1.54 |
Deutsche Telekom AG | DTEL | Mar 27, 2024 | 20.00 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.